Abstract
Flavoproteins are ubiquitous in nature but the ones referred to as flavin-containing monooxygenases, or simply by the acronym FMO, share a catalytic mechanism distinctly different from all other known oxidases or monooxygenases bearing flavin, heme or other redox active prosthetic groups. Like other mammalian monooxygenases, FMO’s require NADPH and oxygen as cosubstrates for the oxygenation of the third substrate but they differ in that the third substrate is not required for the generation of the enzyme bound oxygenating intermediate. Kinetic studies on mechanism (Poulsen and Ziegler, 1979, Beaty and Ballou, 1981a, 1981b) have shown that the xenobiotic substrate is not required for flavin reduction by NADPH nor for reoxidation of dihydroflavin by molecular oxygen. The latter reaction produces the 4a-hydroperoxyflavin which, in FMO, is stabilized by the protein microenvironment around the prosthetic group. The enzyme is apparently present within the cell in this form and any soft nucleophile that can gain access to the enzyme-bound oxygenating intermediate will be oxidized. Precise fit of substrate to enzyme is not necessary, and FMO catalyzes at the same maximum velocity the oxidation of compounds that possess few, if any structural features in common (Ziegler, 1988). These flavoproteins apparently discriminate between physiologically essential and xenobiotic soft nucleophiles by excluding the former rather than by selectively binding the latter. This property is largely responsible for the exceptionally broad specificity of these enzymes. Steric parameters controlling access of nucleophiles to the hydroperoxyflavin apparently differ in various forms of FMO.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Bacq, A. M. (1975). In Sulfur Containing Radioprotective Agents (A. M. Bacq, ed.) p. 8, Pergammon Press, Oxford.
Barker, E. A. and Smukler, E. A. (1972). Altered Microsome Function During Acute Thioacetamide Poisoning. Mol. Pharmacol. 8, 318–326.
Barker, E. A. and Smukler, E. A. (1973). Non-hepatic Thioacetamide Injury: I Thymic Corticol Necrosis. Am. J. Pathol. 71, 409–418.
Beaty, N. S. and Ballou, D. P. (1981a). The Reductive Half-Reaction of Liver Microsomal FAD-Containing Monooxygenase. J. Biol. Chem. 256, 4611–4618.
Beaty, N. S. and Ballou, D. P. (1981b). The Oxidative Half-Reaction of Liver Microsomal FAD-Containing Monooxygenase. J. Biol. Chem. 256, 4619–4625.
Cashman, J. R. and Hanzlik, R. P. (1981). Microsomal Oxidation of Thiobenzamide. A Photometric Assay for the Flavin-Containing Monooxygenase. Biophys. Res. Commun. 98, 147–153.
Chieli, E. and Malvaldi, G. (1984). Role of the Microsomal FAD-Containing Monooxygenase in the Liver Toxicity of Thioacetamide S-Oxide. Toxicology 31, 41–52.
Chieli, E. and Malvaldi, G. (1985). Role of the P-450 and FAD-Containing Monooxygenases in the Bioactivation of Thioacetamide, Thiobenzamides and Their Sulfoxides. Biochem. Pharmacol. 34, 395–396.
Dannan, G. A. and Guengerich, F. P. (1982). Immunochemical Comparison and Quantitation of Microsomal Flavin-Containing Monooxygenase in Various Hog
Mouse, Rat, Rabbit, Dog and Human Tissues. Mo/. Pharmacol. 22, 787–794.
Fitzhugh, O. A. and Nelson, A. A. (1948). Liver Tumors in Rats Fed Thiourea or Thioacetamide. Science 108, 626–628.
Frederick, C. B., Mays, J. B., Ziegler, D. M., Guengerich, F. P. and Kadlubar, F. F. (1982). Cytochrome P-450 and Flavin-Containing Monooxygenase-Catalyzed Formation of the Carcinogen N-Hydroxy-2-Aminofluorene and Its Covalent Binding to Nuclear DNA. Cancer Res. 42, 2671–2677.
Hanzlik, R. P., Cashman, J. P. and Traiger, G. J. (1980). Relative Hepatotoxicity of Thiobenzamides and Thiobenzamide-S-Oxides in the Rat. Toxicol. Appl. Pharmacol. 55, 260–272.
Kreiter, P. A., Ziegler, D. M., Hill, K. A. and Burk, R. F. (1984). Increased Biliary GSSG Efflux from Rat Livers Perfused with Thiocarbamide Substrates for the Flavin-Containing Monooxygenase. Mol. Pharmacol. 26, 122–127.
Liener, J. E. (1980). Toxic Constituents of Plant Foodstuff (J. E. Liener, ed.) 2nd edition, Academic Press Inc., New York.
Lovenberg, W. (1973). Some Vaso-and Psychoactive Substances in Food: Amines, Stimulants, Depressants and Hallucinogens in Toxicants Occurring Naturally in Foods (F. M. Strong, L. Atkin, J. M. Coon, D. W. Fassett, B. J. Wilson and I. A. Wolff) pp. 170–188, National Academy of Sciences, Washington, D.C.
Millard, W. J., Sagar, S. M., Landis, D. M. D., Martin, J. B. and Badger, T. M. (1982). Cysteamine: A Potent and Specific Depletor of Pituitary Prolactin. Science 217, 452–0454.
Nagata, T., Williams, D. E. and Ziegler, D. M. (1990). Substrate Specificities of Rabbit Lung and Porcine Liver Flavin-Containing Monooxygenases: Differences Due to Substrate Size. Chem. Res. Toxicol. (submitted).
Pelroy, R. A., Gandolfi, A. J. (1980). Use of a Mixed Function Amine Oxidase for Metabolic Activation in the Ames/Salmonella Assay System. Mutat. Res. 72, 329–334.
Poulsen, L. L., Hyslop, R. M. and Ziegler, D. M. (1979). S-Oxygenation of N-Substituted Thioureas Catalyzed by the Liver Microsomal FAD-Containing Monooxygenase. Arch. Biochem. Biophys. 198, 78–98.
Poulsen, L. L., Taylor, K., Williams, D. E., Masters, B. S. S. and Ziegler, D. M. (1986). Substrate Specificity of the Rabbit Lung Flavin-Containing Monooxygenase for Amines: Oxidation Products of Primary Alkylamines. Mol. Pharmacol. 30, 680685.
Poulsen, L. L. and Ziegler, D. M. (1977). Microsomal Mixed-Function OxidaseDependent Renaturation of Reduced Ribonuclease. Arch. Biochem. Biophys. 183, 563–570.
Poulsen, L. L. and Ziegler, D. M. (1979). The Liver Microsomal FAD-Containing Monooxygenases: Spectral Characterization and Kinetic Studies. J. Biol. Chem. 254, 6449–6455.
Prough, R. A. and Moloney, S. J. (1985). “Hydrazines” in Bioactivation of Foreign
Compounds (M. M. Anders, ed.) pp. 433–446, Academic Press Inc., New York.
Prough, R. A., Freeman, P. C. and Hines, R. N. (1981). The Oxidation of Hydrazine Derivatives Catalyzed by the Purified Microsomal FAD-Containing Monooxygenase. J. Biol. Chem. 256, 4178–4184.
Prough, R. A. and Ziegler, D. M. (1977). The Relative Participation of Liver Microsomal Amine Oxidase and Cytochrome P-450 in N-Demethylation Reactions. Arch. Biochem. Biophysic. 180, 363–373.
Richter, C. P. (1952). The Physiology and Cytology of Pulmonary Edema and Pleural Effusion Produced in Rats by Alpha-naphthyl Thiourea. J. Thoracic Cardiovac. Surg. 23, 66–91.
Sagar, S. M., Landry, D., Millard, W. J., Badger, T. M., Arnold, M. A. and Martin, J. B. (1982). Depletion of Somatostatin-Like Immunoreactivity in the Rat Central Nervous System by Cysteamine. J. Neuroscience 2, 225–231.
Selye, H. and Szabo, S. (1973). Experimental Model for Production of Perforating Duodenal Ulcers by Cysteamine in the Rat. Nature 244, 458–459.
Smith, R. L. and Williams, R. T. (1961). The Metabolism of Arylthioureas I. The Metabolism of 1,3-Diphenyl-2-thiourea (Thiocarbanilide) and Its Derivatives. J. Med. Pharma. Chem. 4, 97–107.
Sterling, C. J. M. (1974). The Sulfinic Acids and Their Derivatives. Int. J. Sulfur Chem. 6, 277–316.
Tynes, R. E. and Philpot, R. M. (1987). Tissue and Species-Dependent Expression of Multiple Forms of Mammalian Microsomal Flavin-Containing Monooxygenase. Mol. Pharmacol. 31, 569–574.
Tynes, R. E., Sabourin, P. J. and Hodgson, E. (1985). Identification of Distinct Hepatic
and Pulmonary Forms of Microsomal Flavin-Containing Monooxygenase in the
Mouse and Rabbit. Biochem. Biophy. Res. Commun. 126, 1069–1075.
Williams, D. E., Hale, S. E., Meurhoff, A. S. and Masters, B. S. S. (1984a). Rabbit Lung
Flavin-Containing Monooxygenase: Purification, Characterization and Induction During Pregnancy. Mol. Pharmacol. 28, 381–390.
Williams, D. E., Ziegler, D. M., Nordin, D. J., Hale, S. E. and Masters, B. S. S. (1984b). Rabbit Lung Flavin-Containing Monooxygenase is Immunochemically and Catalytically Distinct from the Liver Enzyme. Biochem. Biophys. Res. Commun. 125, 116–122.
Ziegler, D. M. (1988). Flavin-Containing Monooxygenases: Catalytic Mechanism and Substrate Specificities. Drug Meta. Revs. 19, 1–32.
Ziegler, D. M., Ansher, S. S., Nagata, T., Kadlubar, F. F. and Jakoby, W. B. (1988). N-Methylation: Potential Mechanism for Metabolic Activation of Carcinogenic Primary Arylamines. Proc. Natl. Acad. Sci. USA 85, 2514–2517.
Ziegler, D. M., Poulsen, L. L. and Richerson, R. B. (1983). Oxidative Metabolism of Sulfur-Containing Radioprotective Agents in Radioprotective and Anticarcinogens (D. F. Nygaard and M. G. Simic, eds.) pp. 191–202, Academic Press Inc., New York.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Plenum Press, New York
About this chapter
Cite this chapter
Ziegler, D.M. (1991). Bioactivation of Xenobiotics by Flavin-Containing Monooxygenases. In: Witmer, C.M., Snyder, R.R., Jollow, D.J., Kalf, G.F., Kocsis, J.J., Sipes, I.G. (eds) Biological Reactive Intermediates IV. Advances in Experimental Medicine and Biology, vol 283. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-5877-0_4
Download citation
DOI: https://doi.org/10.1007/978-1-4684-5877-0_4
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-5879-4
Online ISBN: 978-1-4684-5877-0
eBook Packages: Springer Book Archive